Christiane Vank

885 total citations
17 papers, 623 citations indexed

About

Christiane Vank is a scholar working on Epidemiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christiane Vank has authored 17 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christiane Vank's work include Urinary Tract Infections Management (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Pediatric Urology and Nephrology Studies (5 papers). Christiane Vank is often cited by papers focused on Urinary Tract Infections Management (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Pediatric Urology and Nephrology Studies (5 papers). Christiane Vank collaborates with scholars based in Israel, United Kingdom and Spain. Christiane Vank's co-authors include Jörg Kaufmann, Klaus Giese, Oliver Keil, Ansgar Santel, Joachim Drevs, Beate Schultheis, Dirk Strumberg, Christian Lange, Michael Khan and Frank Gebhardt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Christiane Vank

17 papers receiving 613 citations

Peers

Countries citing papers authored by Christiane Vank

Since Specialization

Citations

This map shows the geographic impact of Christiane Vank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiane Vank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiane Vank more than expected).

Fields of papers citing papers by Christiane Vank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiane Vank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiane Vank. The network helps show where Christiane Vank may publish in the future.

Co-authorship network of co-authors of Christiane Vank

This figure shows the co-authorship network connecting the top 25 collaborators of Christiane Vank. A scholar is included among the top collaborators of Christiane Vank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiane Vank. Christiane Vank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study 2021 ·European Journal of Clinical Microbiology & Infectious Diseases ·‪Adi Turjeman‬‏, Tanya Babich, Miquel Pujol, Jordi Carratalà, Evelyn Shaw, Aina Gomila‐Grange, Cuong Vuong, (unknown), Irith Wiegand, Sally Grier, Alasdair MacGowan, Christiane Vank, Nienke Cuperus, (unknown), Leonard Leibovici, Noa Eliakim‐Raz, (unknown)	6
2	Risk factors for hospital readmission following complicated urinary tract infection 2021 ·Scientific Reports ·Tanya Babich, Noa Eliakim‐Raz, ‪Adi Turjeman‬‏, Miquel Pujol, Jordi Carratalà, Evelyn Shaw, (unknown), Cuong Vuong, (unknown), Irith Wiegand, Sally Grier, Alasdair MacGowan, Christiane Vank, (unknown), Leonard Leibovici	7
3	Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study 2019 ·Antimicrobial Resistance and Infection Control ·(unknown), Aina Gomila‐Grange, Jordi Carratalà, Noa Eliakim‐Raz, Evelyn Shaw, Cristian Tebé, Martin Wolkewitz, Irith Wiegand, Sally Grier, Christiane Vank, Nienke Cuperus, (unknown), Cuong Vuong, Alasdair MacGowan, Leonard Leibovici, (unknown), Miquel Pujol	36
4	FRI-199-First in Human, single ascending dose clinical trial of AIC649 in patients with chronic hepatitis 2019 ·Journal of Hepatology ·(unknown), Alen Jambrecina, Thomas Berg, Florian van Bömmel, (unknown), Christiane Vank, (unknown), (unknown), (unknown), Manickam Rangaraju, Silke Kummer, (unknown), Adam J. Gehring, Johanna M. Eberhard, Marcus Altfeld, Julian Schulze zur Wiesch, Holger Zimmermann, (unknown)	9
5	Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study 2018 ·SHILAP Revista de lepidopterología ·Aina Gomila‐Grange, Jordi Carratalà, Noa Eliakim‐Raz, Evelyn Shaw, Irith Wiegand, Laura Vallejo‐Torres, (unknown), (unknown), Stephen Morris, (unknown), Sally Grier, Christiane Vank, Nienke Cuperus, (unknown), Cuong Vuong, Alasdair MacGowan, Leonard Leibovici, (unknown), Miquel Pujol	2
6	Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study 2018 ·BMJ Open ·Laura Vallejo‐Torres, Miquel Pujol, Evelyn Shaw, Irith Wiegand, (unknown), (unknown), Sally Grier, Julie Gibbs, Christiane Vank, Nienke Cuperus, (unknown), Noa Eliakim‐Raz, Jordi Carratalà, Cuong Vuong, Alasdair MacGowan, Tanya Babich, Leonard Leibovici, (unknown), Stephen Morris	48
7	Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections 2018 ·Antimicrobial Resistance and Infection Control ·Aina Gomila‐Grange, Evelyn Shaw, Jordi Carratalà, Leonard Leibovici, Cristian Tebé, Irith Wiegand, Laura Vallejo‐Torres, (unknown), Stephen Morris, (unknown), Sally Grier, Christiane Vank, Nienke Cuperus, (unknown), Noa Eliakim‐Raz, Cuong Vuong, Alasdair MacGowan, (unknown), Miquel Pujol, (unknown)	47
8	Risk factors and prognosis of complicated urinary tract infections caused by <em>Pseudomonas aeruginosa</em> in hospitalized patients: a retrospective multicenter cohort study 2018 ·Infection and Drug Resistance ·(unknown), Jordi Carratalà, Noa Eliakim‐Raz, Evelyn Shaw, Irith Wiegand, Laura Vallejo‐Torres, (unknown), (unknown), Stephen Morris, (unknown), Sally Grier, Christiane Vank, Nienke Cuperus, (unknown), Cuong Vuong, Alasdair MacGowan, Leonard Leibovici, (unknown), Miquel Pujol	33
9	Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING) 2016 ·BMJ Open ·Evelyn Shaw, (unknown), (unknown), Christiane Vank, Sally Grier, Irith Wiegand, Leonard Leibovici, Noa Eliakim‐Raz, Laura Vallejo‐Torres, Stephen Morris, Alasdair MacGowan, Jordi Carratalà, Miquel Pujol	6
10	First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors 2014 ·Journal of Clinical Oncology ·Beate Schultheis, Dirk Strumberg, Ansgar Santel, Christiane Vank, Frank Gebhardt, Oliver Keil, Christian Lange, Klaus Giese, Jörg Kaufmann, Michael Khan, Joachim Drevs	206
11	Antimetastatic activity of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3): Final results of a phase I study in patients with advanced solid tumors. 2012 ·Journal of Clinical Oncology ·Dirk Strumberg, Beate Schultheis, W. Meyer‐Sabellek, Christiane Vank, Frank Gebhardt, Ansgar Santel, Oliver Keil, Klaus Giese, Jörg Kaufmann, Joachim Drevs	4
12	Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors 2011 ·International Journal of Clinical Pharmacology and Therapeutics ·Dirk Strumberg, Beate Schultheis, (unknown), Christiane Vank, Ansgar Santel, Oliver Keil, Klaus Giese, Jörg Kaufmann, Joachim Drevs	112
13	First-in-human phase I study of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3) in patients with advanced solid tumors. 2011 ·Journal of Clinical Oncology ·Dirk Strumberg, Beate Schultheis, (unknown), Christiane Vank, Ansgar Santel, Oliver Keil, Klaus Giese, Jörg Kaufmann, Joachim Drevs	7
14	Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models 2010 ·Clinical Cancer Research ·Ansgar Santel, Manuela Aleku, Nadine Röder, Kristin Möpert, Birgit Durieux, Oliver Janke, Oliver Keil, Jens Endruschat, Sibylle Dames, Christian Lange, (unknown), Kathrin Löffler, Melanie Fechtner, Gerald Fisch, Christiane Vank, Ute Schaeper, Klaus Giese, Jörg Kaufmann	81
15	The forskolin-induced opening of tight junctions in Xenopus gallbladder epithelium is mediated by protein kinase C. 2003 ·PubMed ·Gábor Kottra, Christiane Vank	7
16	Activation of an apical Cl– conductance by extracellular ATP in Necturus gallbladder is mediated by cAMP and not by [Ca2+]i 1999 ·Pflügers Archiv - European Journal of Physiology ·Christiane Vank, E. Frömter, Gábor Kottra	8
17	The activation of an apical Cl– conductance by extracellular ATP is potentiated by genistein in Necturus gallbladder epithelium 1999 ·Pflügers Archiv - European Journal of Physiology ·Christiane Vank, E. Frömter, Gábor Kottra	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact